The increased expression of NF-κB signaling pathway (121, 122) and NF-κB-mediated cytokines (120), such as IL-1 in OPMD and OSCC, are reported to have impact in clinical outcomes (120, 123). The gene discussed is NFKB1; the disease is oculopharyngeal muscular dystrophy.